Title : (68)Ga-Fibroblast Activation Protein Inhibitor PET\/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical Therapy - Lanzafame_2024_J.Nucl.Med_65_880 |
Author(s) : Lanzafame H , Mavroeidi IA , Pabst KM , Desaulniers M , Ingenwerth M , Hirmas N , Kessler L , Nader M , Bartel T , Leyser S , Barbato F , Schuler M , Bauer S , Siveke JT , Herrmann K , Hamacher R , Fendler WP |
Ref : J Nucl Med , 65 :880 , 2024 |
Abstract : |
PubMedSearch : Lanzafame_2024_J.Nucl.Med_65_880 |
PubMedID: 38724279 |
Title : Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities - Hirmas_2023_J.Nucl.Med_64_711 |
Author(s) : Hirmas N , Hamacher R , Sraieb M , Ingenwerth M , Kessler L , Pabst KM , Barbato F , Lueckerath K , Kasper S , Nader M , Schildhaus HU , Kesch C , von Tresckow B , Hanoun C , Hautzel H , Aigner C , Glas M , Stuschke M , Kummel S , Harter P , Lugnier C , Uhl W , Niedergethmann M , Hadaschik B , Grunwald V , Siveke JT , Herrmann K , Fendler WP |
Ref : J Nucl Med , 64 :711 , 2023 |
Abstract : |
PubMedSearch : Hirmas_2023_J.Nucl.Med_64_711 |
PubMedID: 36581374 |
Title : Inhibition of butyrylcholinesterase by organophosphorus compounds: a quantitative structure-activity analysis - Barbato_1982_Farmaco.Sci_37_519 |
Author(s) : Barbato F , Cappello B , Silipo C , Vittoria A |
Ref : Farmaco Sci , 37 :519 , 1982 |
Abstract : |
PubMedSearch : Barbato_1982_Farmaco.Sci_37_519 |
PubMedID: 7128809 |